The seroprevalence of SARS-CoV-2 infection in Malaysia: 7 August to 11 October 2020.
Chong Zhuo LinWan Shakira Rodzlan HasaniFilza Noor AsariEida Nurhadzira MuhammadMohd Hatta Abdul MutalipTania Gayle Robert LourdesHalizah Mat RifinSarbhan SinghRavindran ThayanPublished in: Influenza and other respiratory viruses (2023)
Our study revealed a low pre-variant and pre-vaccination seroprevalence of SARS-CoV-2 infection in Malaysia up to mid-October 2020, with a considerable proportion of asymptomatic and undiagnosed cases. This led to subsequent adoption of SARS-CoV-2 antigen rapid test kits to increase case detection rate and to reduce time to results and infection control measures.